Highlight
- The Predictive Aplastic Score System (PASS) is a validated clinical tool that distinguishes acquired aplastic anemia (AA) from inherited bone marrow failure syndromes (IBMFS) in adults without immediate genetic testing.
- PASS uses seven readily available clinical and laboratory variables, achieving excellent diagnostic accuracy, with an AUC of 0.990 in the training cohort and 0.977 in external validations.
- The model provides 100% positive predictive value for AA at scores ≥30, enabling rapid clinical decision-making and potentially reducing reliance on time-consuming or inaccessible genetic tests.
- PASS facilitates differentiation in approximately 80% of adult cases, improving early diagnosis and appropriate treatment selection.
Background
Specialty calculators
For clinical reference; use professional judgment.
